Single-fraction radiotherapy with a bioactive depot of CD39 blockade eradicates malignant tumors
Fields of Study & Subjects
Adenosine and Purinergic Signaling
Cancer Immunotherapy and Biomarkers
Nanoplatforms for cancer theranostics
Publication details
- Journal / source
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Volume
- 391
- Pages
- 114632–114632
- Publication date
- 13 January 2026
- Language
- EN